Physician

Ali Abdelmutaal Omar Mohamed, M.D.

According to 2025 Medicare claims, Ali Mohamed, M.D. (NPI: 1144489287) practices hematology/oncology, with the plurality of this provider's patient population coming from Chippewa, MI. This provider's primary affiliated billing organization is REED CITY HOSPITAL CORPORATION (NPI: 1831253798; TIN: 382770076) and primary practice location at 49783-2071. Mohamed is affiliated with the POM ACO (ACO ID: A1297), West Michigan Accountable Care Organization, LLC (ACO ID: A4626), Collaborative ACO 30, LLC (ACO ID: A5483), Honest MSSP of Michigan LLC (ACO ID: A5616), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mohamed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 174 traditional Medicare patients, billed 475 HCPCS/CPT codes, and received $32,868 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 402 prescription claims across 100 beneficiaries totaling $786,753 in drug costs, led by Lenalidomide (Lenalidomide). 2023 DME data shows 11 claims. Open Payments data shows 2 records totaling $132. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $74,616 to $786,753. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,155 and ending at $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	139	391	$26,962
2016	120	452	$33,333
2017	188	503	$36,569
2018	167	502	$35,631
2019	184	564	$41,939
2020	160	530	$35,300
2021	148	405	$28,770
2022	101	258	$22,163
2023	156	338	$25,748
2024	174	475	$32,868

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	99	365	$74,616
2016	45	288	$38,517
2017	63	333	$182,872
2018	49	258	$194,247
2019	62	209	$133,122
2020	67	262	$194,556
2021	53	144	$253,790
2022	39	186	$627,704
2023	61	235	$609,179
2024	100	402	$786,753

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$780
2016	N/R	226	$26,932
2017	26	245	$28,011
2018	66	331	$18,434
2019	36	421	$34,243
2020	68	479	$38,636
2021	N/R	100	$2,450
2022	N/R	N/R	N/R
2023	N/R	11	$6,664
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	35	35	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	26	54	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	115	223	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	114	155	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	14	392	$211,964
Pazopanib Hcl	Pazopanib Hcl	12	360	$135,191
Abiraterone Acetate	Abiraterone Acetate	28	840	$129,486
Eliquis	Apixaban	11	384	$6,870
Imatinib Mesylate	Imatinib Mesylate	25	716	$3,060

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$132	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Abdelmutaal Omar Mohamed, M.D.?

Tedicare shows public-source Medicare data for Ali Abdelmutaal Omar Mohamed, M.D. (NPI 1144489287), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Abdelmutaal Omar Mohamed, M.D. have ACO affiliation data?

Ali Abdelmutaal Omar Mohamed, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), Honest MSSP of Michigan LLC (MSSP, ACO ID A5616), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ali Abdelmutaal Omar Mohamed, M.D.?

Ali Abdelmutaal Omar Mohamed, M.D. is linked to REED CITY HOSPITAL CORPORATION (billing NPI 1831253798) in the available physician profile data.

Does Ali Abdelmutaal Omar Mohamed, M.D. have Open Payments data?

Ali Abdelmutaal Omar Mohamed, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.